Clinical Trial Update: Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating extended weekly infusions of carfilzomib in patients with advanced solid tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasms

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Emory University | Conditions: Neoplasms, Malignancies | Phase 1 | Status: COMPLETED